Zimmer Biomet
ZBHS&P 500
96,13 $
Dividend yield0,52 %
Continuity15 yr
Dividend0,48 $
DiviScore
RiskPerformance4/35
Dividend Quality17/35
AGM Date
—Ex-Date
25.06.2026Payment
—CAGR 3Y
-9.2%CAGR 5Y
-7.7%CAGR 10Y
-2.8%€10,000 invested in 2016 · with dividend reinvestment
End Value
8.189,25 $
Total Return
+-18.1%
Annual Return
-2.0% p.a.
Dividends Received
800,53 $
Dividend history
Quarterly Results
About Zimmer Biomet
Zimmer Biomet is a leading maker of orthopaedic implants and surgical products, specialising in hip and knee replacements alongside a broad range of musculoskeletal devices. An ageing population and rising rates of joint replacement support long-term demand, though the market is competitive and pricing pressure is a persistent headwind. The company reinstated its dividend a few years ago after an earlier suspension, so its record of increases is still relatively short. The yield is low and the payout modest, meaning income is a secondary feature of a stock driven more by its medical-device growth prospects and margin recovery.
Frequently Asked Questions
The next payment date is not yet announced.
Zimmer Biomet has a DiviScore of 40/100. DiviScore rates dividend stocks based on price performance, dividend quality, fundamentals, and stability.
Zimmer Biomet's current dividend yield is 0.52% based on the latest dividend.
Zimmer Biomet (ZBH) is a member of S&P 500. Current data including price, dividend, and DiviScore is updated daily.
DiviScore is a proprietary 100-point rating based on four pillars: Performance (35 pts), Dividend Quality (35 pts), Fundamentals (15 pts), and Stability (15 pts). It simulates a 10-year investment with automatic dividend reinvestment.